- Make or break: Commercial hires critical for successWith the stakes for successful launches high, and demand for commercial roles increasing, biopharmas must thoughtfully approach not only hiring but also retention. During a BioSpace webinar, experi…BioSpace · 1d ago↗ source
- Biopharma layoffs must double in H2 for 2026 to match 2025 cutsWith fewer biopharmas making or planning workforce reductions so far year over year, layoff round size and M&A impact on headcounts will likely shape the number of employees who are ultimately on t…BioSpace · 1d ago↗ source
- Recon: J&J nabs FDA authorization for general surgery robot; FDA urged to ban DTC drug ads<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps